News

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.
The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
First results from NHS patients getting Wegovy through an app show treatment via smartphone works as well as in-person ...